Dalpicilib

DRUG2 trials

Sponsors

Qilu Hospital of Shandong University, Fudan University

Conditions

Breast CancerThe Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

Not yet recruitingNCT06500247

Qilu Hospital of Shandong UniversityThe Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Start: 2024-07-31End: 2027-03-31Target: 43Updated: 2024-07-15

Phase 3

Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer

Active, not recruitingNCT06637150

Fudan UniversityBreast Cancer

Start: 2024-09-01End: 2030-09-30Target: 1388Updated: 2024-10-15